GlaxoSmithKline | GSK

Stock Price
1,770.50
Daily Change
-5.00 -0.28%
Monthly
-5.27%
Yearly
17.76%
Q3 Forecast
1,737.04

EPS Reference Time Actual Consensus Previous
2026-10-28 FY2026Q3 AM 0.53 0.55
2026-07-29 FY2026Q2 AM 0.51 0.45 0.47
2026-04-29 FY2026Q1 AM 0.43 0.43 0.45
2026-02-04 FY2025Q4 AM 0.26 0.24 0.23
2025-10-29 FY2025Q3 AM 0.55 0.47 0.50



Peers Price Chg Day Year Date
AbbVie 257.12 2.12 0.83% 17.76% Sep/11
Alcon AG 53.98 -0.52 -0.95% -13.85% Sep/11
Almirall 10.20 0.06 0.59% -8.44% Sep/11
Amgen 377.35 -5.12 -1.34% 36.53% Sep/11
argenx SE 853.80 -2.00 -0.23% 32.50% Sep/11
AstraZeneca 11,708.00 -50.00 -0.43% -0.73% Sep/11
Bayer 48.17 -0.53 -1.09% 71.61% Sep/11
Biogen 217.15 1.72 0.80% 49.90% Sep/11
Bristol-Myers Squibb 63.64 -0.11 -0.17% 37.75% Sep/11
Fresenius Medical Care 38.44 -0.05 -0.13% -9.55% Sep/11

Indexes Price Day Year Date
GB100 10650 41.52 0.39% 14.73% Sep/11
EU600 639 3.13 0.49% 15.19% Sep/11

GlaxoSmithKline traded at 1,770.50 this Friday September 11th, decreasing 5.00 or 0.28 percent since the previous trading session. Looking back, over the last four weeks, GlaxoSmithKline lost 5.27 percent. Over the last 12 months, its price rose by 17.76 percent. Looking ahead, we forecast GlaxoSmithKline to be priced at 1,737.04 by the end of this quarter and at 1,640.40 in one year, according to Trading Economics global macro models projections and analysts expectations.

GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines and vaccines products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a range of acute and chronic diseases. The Vaccines business provides vaccines for people of all ages from babies and adolescents to adults and older people. It has a portfolio of medicines in respiratory and HIV. Its Pharmaceuticals business includes Respiratory, HIV, Specialty products, and Classic and Established products. Its Vaccines business has a portfolio of over 40 pediatric, adolescent, adult, older people and travel vaccines.



News Stream
GlaxoSmithKline Stock Price Hits 16-week Low
GlaxoSmithKline shares decreased to 1801.00 GBp, the lowest since May 2026. Over the past 4 weeks, GlaxoSmithKline lost 6.41%, and in the last 12 months, it increased 20.99%.
2026-09-08
GlaxoSmithKline Stock Price Hits 9-week Low
GlaxoSmithKline shares decreased to 1850.00 GBp, the lowest since June 2026. Over the past 4 weeks, GlaxoSmithKline lost 5.13%, and in the last 12 months, it increased 29.15%.
2026-08-12
GlaxoSmithKline Stock Price Hits 8-week High
GlaxoSmithKline shares increased to 2052.00 GBp, the highest since May 2026. Over the past 4 weeks, GlaxoSmithKline gained 3.44%, and in the last 12 months, it increased 46.56%.
2026-07-28